海泰新光跌0.68%，成交额5012.81万元，近3日主力净流入-850.63万

Core Viewpoint - The company, Qindao Haitai New Light Technology Co., Ltd., is focused on integrating optical technology with cutting-edge applications in the medical device industry, particularly in high-performance endoscopic instruments [2]. Group 1: Company Overview - The company was established on June 11, 2003, and went public on February 26, 2021. Its main business includes the research, development, production, and sales of medical endoscopic instruments and optical products [7]. - The revenue composition of the company is as follows: 64.86% from medical endoscopic instruments, 21.63% from optical products, 13.09% from maintenance services, and 0.42% from leasing [7]. - As of September 30, the company reported a revenue of 448 million yuan for the period from January to September 2025, representing a year-on-year growth of 40.47%, and a net profit attributable to shareholders of 136 million yuan, also showing a growth of 40.03% [7]. Group 2: Market Position and Recognition - The company has been recognized as a "specialized, refined, distinctive, and innovative" small giant enterprise, which is a prestigious title in China for small and medium-sized enterprises that excel in niche markets and possess strong innovation capabilities [3]. - The company has a significant international presence, with overseas revenue accounting for 69.12% of total revenue, benefiting from the depreciation of the RMB [3]. Group 3: Financial and Trading Analysis - On February 26, the company's stock price decreased by 0.68%, with a trading volume of 50.13 million yuan and a turnover rate of 0.89%, resulting in a total market capitalization of 5.575 billion yuan [1]. - The average trading cost of the stock is 46.89 yuan, with the stock price currently near a support level of 46.27 yuan, indicating potential for a rebound if this support holds [6]. - The main capital flow shows a net outflow of 5.26 million yuan today, with the stock's main capital trend being unclear [4][5].